[go: up one dir, main page]

MX2015003074A - Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas. - Google Patents

Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.

Info

Publication number
MX2015003074A
MX2015003074A MX2015003074A MX2015003074A MX2015003074A MX 2015003074 A MX2015003074 A MX 2015003074A MX 2015003074 A MX2015003074 A MX 2015003074A MX 2015003074 A MX2015003074 A MX 2015003074A MX 2015003074 A MX2015003074 A MX 2015003074A
Authority
MX
Mexico
Prior art keywords
ergothioneine
idebenone
farnesyl
cysteine
acetyl
Prior art date
Application number
MX2015003074A
Other languages
English (en)
Inventor
Jose Fernandez
Eduardo Perez
Maxwell Stock
Lavinia Codruta Popescu
Aurelie Nathalie Felix-Gonnot
Arthur Joseph Pellegrino
Original Assignee
Arden Elizabeth Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arden Elizabeth Inc filed Critical Arden Elizabeth Inc
Publication of MX2015003074A publication Critical patent/MX2015003074A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a composiciones que mitigan el daño causado por factores de estrés ambientales. Los factores de estrés incluyen, pero no se limitan a, daño causado por radiación ultra-violeta. Las composiciones comprenden una cantidad efectiva de idebenona o un derivado de la misma, N-acetil-S-farnesil-L-cist eína o una sal o éster de la misma farmacéuticamente aceptable y ergotioneína o una sal o éster de la misma farmacéuticamente aceptable. En algunas modalidades estas composiciones son aplicadas tópicamente a la piel de una persona.
MX2015003074A 2012-09-14 2013-09-11 Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas. MX2015003074A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261701098P 2012-09-14 2012-09-14
US201361815771P 2013-04-25 2013-04-25
PCT/US2013/059257 WO2014043230A2 (en) 2012-09-14 2013-09-11 Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof

Publications (1)

Publication Number Publication Date
MX2015003074A true MX2015003074A (es) 2015-11-09

Family

ID=50278844

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015003074A MX2015003074A (es) 2012-09-14 2013-09-11 Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.

Country Status (15)

Country Link
US (1) US20160243011A1 (es)
EP (1) EP2895159A4 (es)
JP (1) JP2015528499A (es)
KR (1) KR20150055024A (es)
CN (1) CN104853753A (es)
AU (1) AU2013315557A1 (es)
BR (1) BR112015005789A2 (es)
CA (1) CA2884115A1 (es)
HK (1) HK1206621A1 (es)
IL (1) IL237693A0 (es)
MX (1) MX2015003074A (es)
RU (1) RU2015112839A (es)
SG (1) SG11201501892SA (es)
WO (1) WO2014043230A2 (es)
ZA (1) ZA201501857B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036528A2 (en) 2012-08-31 2014-03-06 Ixchel Pharma, Llc Agents useful for treating obesity, diabetes and related disorders
PT107561A (pt) * 2014-04-01 2015-10-01 Amorim Cork Res Lda Extracto hidro-glicólico de cortiça, processo para a sua preparação, formulações compreendendo o referido extracto e sua utilização
AU2016233559A1 (en) 2015-03-13 2017-11-02 Mironova Innovations, Llc Nalpha, Nalpha, Nalpha-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds
US10363207B2 (en) * 2016-04-29 2019-07-30 Purvisha Patel All-in-one skin-brightening formulations
CN109276578A (zh) * 2018-11-07 2019-01-29 上海上水和肌化妆品有限公司 由能量转换促进皮肤抗醣化作用的组合物及其制备方法
JP7727671B2 (ja) * 2021-02-03 2025-08-21 長瀬産業株式会社 ホモシステイン誘導体及びその製造方法、組成物、並びに、炎症抑制剤
CN115350167A (zh) * 2022-09-29 2022-11-18 陕西中鸿科瑞再生医学研究院有限公司 艾地苯醌在制备降尿酸药物中的应用
CN115645296B (zh) * 2022-11-15 2024-04-26 杭州唯铂莱生物科技有限公司 一种化妆品组合物、制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
WO2005123103A1 (en) * 2004-06-12 2005-12-29 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
US20060263320A1 (en) * 2005-05-17 2006-11-23 The Procter & Gamble Company Regulation of mammalian keratinous tissue using personal care compositions comprising ergothioneine
CN101175467A (zh) * 2005-05-17 2008-05-07 宝洁公司 使用包含四氢姜黄素的个人护理组合物调节哺乳动物的角质组织
WO2010051138A2 (en) * 2008-10-06 2010-05-06 Pharma Cosmetix Research, Llc Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof

Also Published As

Publication number Publication date
AU2013315557A1 (en) 2015-03-26
US20160243011A1 (en) 2016-08-25
KR20150055024A (ko) 2015-05-20
RU2015112839A (ru) 2016-11-10
WO2014043230A3 (en) 2014-07-10
EP2895159A4 (en) 2016-06-08
WO2014043230A2 (en) 2014-03-20
HK1206621A1 (en) 2016-01-15
EP2895159A2 (en) 2015-07-22
JP2015528499A (ja) 2015-09-28
ZA201501857B (en) 2016-10-26
CN104853753A (zh) 2015-08-19
IL237693A0 (en) 2015-05-31
CA2884115A1 (en) 2014-03-20
SG11201501892SA (en) 2015-04-29
BR112015005789A2 (pt) 2018-06-26

Similar Documents

Publication Publication Date Title
MX2015003074A (es) Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
PH12016500024A1 (en) Bromodomain inhibitor
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
WO2014062720A3 (en) Methods of treating cancer
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
NZ603151A (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
WO2014108846A3 (en) Soothing cosmetic composition based on salicylic acid
IN2015DN03069A (es)
WO2011117377A3 (en) Compositions comprising brimonidine for the treatment of erythema
MX346576B (es) Metodos y composiciones adecuados para promover piel sana.
MX2021004211A (es) Composiciones vacuna.
WO2011117378A3 (en) Compositions comprising brimonidine for the treatment of erythema
MY173573A (en) Pyridin-4-yl derivatives
WO2012170695A3 (en) Sunscreen formulations
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
WO2014182789A3 (en) Radiomitigating pharmaceutical formulations
HK1215391A1 (zh) 使用胎盘细胞外基质治疗口腔病变
MX373541B (es) Gel de acido salicilico.
PH12016500910A1 (en) Long-acting ketoprofen compositions
WO2013190542A3 (en) Topical compositions for the treatment of chronic inflammatory skin disease
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
IT1401289B1 (it) Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono